Up to 40% of patients with chronic edema are hospitalized each year for preventable complications.
Recurrent cellulitis, non-healing wounds, and readmissions drive avoidable costs and penalties for health plans.
With structured, in-home care, these events can be reduced by 30–40%, improving member outcomes and lowering spend.
Chronic edema is rarely managed systematically, yet it contributes significantly to utilization and costs across high-risk populations. Traditional outpatient or home-health models often fail due to poor adherence, lack of specialization, and limited coordination. By addressing edema comprehensively in the home, EdemaCare closes this care gap — preventing complications, reducing hospital use, and improving quality performance measures for plans and systems.
We track inpatient and observation episodes for enrolled patients and trend changes over time, with attention to edema-driven complications (skin breakdown, infection risk, uncontrolled swelling). Events are captured through available utilization notifications and documented care coordination outreach. When partner utilization reporting is available, we reconcile and validate trends.
We track inpatient and observation episodes for enrolled patients and trend changes over time, with attention to edema-driven complications (skin breakdown, infection risk, uncontrolled swelling). Events are captured through available utilization notifications and documented care coordination outreach. When partner utilization reporting is available, we reconcile and validate trends.
We monitor skin integrity at every visit and document changes such as new breakdown, worsening drainage, signs of infection risk, and need for escalation to the referring provider. Complication rates are tracked as documented clinical events over time for the enrolled population. This is paired with adherence to compression, skin care routines, and early identification workflows that reduce preventable deterioration.
We monitor skin integrity at every visit and document changes such as new breakdown, worsening drainage, signs of infection risk, and need for escalation to the referring provider. Complication rates are tracked as documented clinical events over time for the enrolled population. This is paired with adherence to compression, skin care routines, and early identification workflows that reduce preventable deterioration.
Time to first visit is calculated as the number of calendar days from receipt of a complete referral (required demographics, clinical indication, and payer information) to the first completed in-home evaluation/visit. We track this across all new-start patients during the measurement window and monitor delays separately (referral completeness, authorization timing, patient scheduling barriers).
Symptom improvement is measured using standardized patient-reported check-ins collected at intake and follow-up, focusing on swelling, heaviness/tightness, discomfort, and functional mobility (walking tolerance, stairs, and daily activities). The reported percentage reflects patients who indicated improvement compared to their baseline during the measurement period.
Patient satisfaction is measured through short post-visit and periodic check-in surveys completed by patients and/or caregivers. Responses are compiled across the measurement period and reported as the percent of respondents who selected “Satisfied” or “Very Satisfied.” Feedback is reviewed by our leadership team to improve scheduling, education, and consistency of in-home care.
Patient satisfaction is measured through short post-visit and periodic check-in surveys completed by patients and/or caregivers. Responses are compiled across the measurement period and reported as the percent of respondents who selected “Satisfied” or “Very Satisfied.” Feedback is reviewed by our leadership team to improve scheduling, education, and consistency of in-home care.